Prostate cancer (PCa) is the most common male malignancy and the fifth leading cause of
cancer death in men worldwide. Prostate cancer cells are characterized by a hybrid …

Context Neoplastic cells are characterized by metabolic alterations that sustain tumor
growth. Interventions aimed at modifying metabolic rewiring of cancer cells are currently …

Prostate cancer (PCa), one of the most commonly diagnosed cancers worldwide, still
presents important unmet clinical needs concerning treatment. In the last years, the …

Prostate cancer is one of the most common types of cancer in western country males but the
mechanisms involved in the transformation processes have not been clearly elucidated …

Metabolic reprogramming is one of the main hallmarks of cancer cells. It refers to the
metabolic adaptations of tumor cells in response to nutrient deficiency, microenvironmental …

Introduction: An altered metabolic regulation is involved in the development and progression
of different cancer types. As well as this, many genes associated with tumors are shown to …

Metabolic reprogramming has been recognised as a hallmark in solid tumours. Malignant
modification of the tumour's bioenergetics provides energy for tumour growth and …

Prostate cancer (PCa) is a global health problem that affects millions of men every year. In
the past decade, metabolomics and related subareas, such as lipidomics, have …

Prostate cancer invokes major shifts in gene transcription and metabolic signaling to
mediate alterations in nutrient acquisition and metabolic substrate selection when compared …

Simple Summary Prostate cancer (PCa) is a hormone-dependent tumor characterized by a
highly heterogeneous clinical outcome. This neoplastic process has become a leading …